TrademarkDir
IMMUNESCORE
LIVE

Serial Number

79124781

Owner

INSERM (Institut National de la Santé et de la Recherche Médicale)

Attorney

Cathleen E. Stadecker

Filing Date

Aug 10, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMMUNESCORE Trademark

Serial Number: 79124781 • Registration: 4508543

IMMUNESCORE is a trademark filed by INSERM (Institut National de la Santé et de la Recherche Médicale) on August 10, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

INSERM (Institut National de la Santé et de la Recherche Médicale) (4 trademarks)

101 rue de Tolbiac

Entity Type: 99

Trademark Details

Filing Date

August 10, 2012

Registration Date

April 8, 2014

Published for Opposition

January 21, 2014

Cancellation Date

August 11, 2022

Goods & Services

Microscopes; scanners; computer programs recorded on software and data-computing software for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; and image analysis software

Chemical reagents for medical or veterinary use; clinical medical reagents; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical use; chemical, pharmaceutical and biological preparations for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; and antibodies for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments

Cultures of microorganisms other than for medical and veterinary use; diagnostic preparations of microorganisms for scientific purposes, for diagnostic purposes, and for laboratory or research use; chemical reagents other than for medical or veterinary use; biomolecule marking kits comprising reagents for scientific research; reagents for scientific applications; and antibodies for scientific use

Medical assistance; hospital services; health care; performing diagnosis of diseases, namely, cancer, and providing information in the field of cancer diagnosis

Medical and diagnostic apparatus and instruments for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; microscopes for medical use; high-resolution scanners for use in scientific and medical research; and tissue sample preparation devices for medical diagnostic uses, namely, detecting abnormal cancer cells

Research and development of pharmaceutical products; software design; software design and development; design, maintenance and updating of software; software consultancy

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 26, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 26, 2023 DETH
NEW REPRESENTATIVE AT IB RECEIVED
May 28, 2022 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Feb 19, 2022 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Jan 26, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 26, 2022 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Dec 12, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2019 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 8, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 14, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 11, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 11, 2014 FICS
FINAL DISPOSITION PROCESSED
Aug 11, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 8, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jan 16, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 1, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 16, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 16, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 16, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 16, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 16, 2013 CNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 18, 2013 CHAN
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 13, 2013 EWAF
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2013 CRFA
ASSIGNED TO LIE
Sep 3, 2013 ALIE
ASSIGNED TO LIE
Aug 26, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2013 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 16, 2013 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 18, 2013 TCCA
REFUSAL PROCESSED BY IB
Mar 11, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 21, 2013 RFCS
REFUSAL PROCESSED BY MPU
Feb 21, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2013 RFCR
NON-FINAL ACTION WRITTEN
Feb 20, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 19, 2013 MAFR
ASSIGNED TO EXAMINER
Feb 13, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2013 REPR

Related Trademarks

More from this Owner

ORPHANET

ORPHANET

ORPHANET

ORPHANET

ORPHANET

ORPHANET

EMBRYOSCAN

EMBRYOSCAN

IMMUNOSCORE

IMMUNOSCORE

IMMUNOSCORE

IMMUNOSCORE